p38 Mitogen-Activated Protein Kinase (MAPK) Increases Arginase Activity and Contributes to Endothelial Dysfunction in Corpora Cavernosa from Angiotensin-II-Treated Mice

Add time:08/12/2019    Source:sciencedirect.com

ABSTRACTIntroductionAngiotensin II (AngII) activates p38 mitogen-activated protein kinase (MAPK) and elevates arginase activity in endothelial cells. Upregulation of arginase activity has been implicated in endothelial dysfunction by reducing nitric oxide (NO) bioavailability. However, signaling pathways activated by AngII in the penis are largely unknown.

We also recommend Trading Suppliers and Manufacturers of angiotensin I, (beta-(4-pyridyl-1-oxide)-Ala(4))- (cas 132488-66-5). Pls Click Website Link as below: cas 132488-66-5 suppliers

Prev:Multicomponent Hantzsch cyclocondensation as a route to highly functionalized 2- and 4-dihydropyridylalanines, 2- and 4-pyridylalanines, and their N-oxides: preparation via a polymer-assisted solution-phase approach
Next:Two efficient methods for the cleavage of pinanediol boronate esters yielding the free boronic acids)